中国金丝桃属植物民族药理学综述:民族植物学、植物化学与药理学
该综述系统梳理了中国金丝桃属植物的民族药用、植物化学与药理研究。中国记录64种金丝桃属植物,其中30种被15个语言族群用作民族药,具有抗肿瘤、抗炎、抗菌、神经保护、抗抑郁等活性,主要成分包括间苯三酚类、萘骈二蒽酮类、𠮿酮类、黄酮类和萜类。近半数种类研究甚少,需开展机制、药理学、临床疗效及资源与质量控制研究。
要点
- 中国64种金丝桃属植物中30种被15个语言族群用作民族药。
- 金丝桃属具有抗肿瘤、抗炎、抗菌、神经保护、抗抑郁等 reported 活性。
- 近半数中国金丝桃属种类缺乏科学研究,民族药用潜力待评估。
核心结论
- 中国金丝桃属植物民族药用知识丰富,是抗癌及慢性病药物潜在来源。
- 近半数种类研究甚少,其民族药用潜力尚未得到科学评估。
研究设计与样本
- 综述检索经典医药书籍及SciFinder、Science Direct、PubMed、Google Scholar、CNKI等数据库1959至2019年文献。
主要发现
- 中国记录64种金丝桃属植物,30种被 Dai、Dong、Han、Miao、Mongolian 等15个语言族群用作民族药。
- 中国金丝桃属传统用途与欧、美、非及亚洲其他国家相似,但也有独特用途,如西南地区局部用药、东北用 H. attenuatum Fisch. ex Choisy 治疗心脏疾病。
- 药理研究报道抗肿瘤、抗炎、抗菌、神经保护、抗抑郁、保肝、心脏保护及抗病毒活性。
- 主要植物化学成分包括间苯三酚类、萘骈二蒽酮类、𠮿酮类、黄酮类和萜类。
临床怎么用
- 可参考中国金丝桃属民族药用经验,优先研究与传统用途密切相关的种类。
- 关注具有抗肿瘤、抗炎、抗菌、神经保护等活性的金丝桃属植物成分。
局限性
- 近半数中国金丝桃属种类鲜有研究,民族药用潜力未获科学评估。
- 需开展体外机制研究、体内药理学、临床疗效、植物资源评估、质量控制及毒理学研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Hypericum species have been used traditionally as astringent, antipyretic, diuretic, antiphlogistic, analgesic, and antidepressant in Europe, America, Africa, and Asia. One of the most extensively investigated medicinal herbs, H. perforatum L. (St. John's wort), is widely used in many countries to treat mild to moderate mental depression. Hypericum species are abundant throughout China, including 30 used as ethnomedicines. There are limited publications describing the ethnobotanical uses and biological activities associated with Hypericum species in China. Some reported activities include the treatment of wounds and bruises, irregular menstruation, dysentery, hepatitis, mastitis, jaundice, hemoptysis, and epistaxis. AIM OF THE REVIEW: This review aims to critically examine how Hypericum species are used ethnomedicinally in China, to see if the ethnobotanical data may be useful to help prioritize Hypericum species and certain phytochemical constituents that may be new drug leads, and consider the focus and lack of the phytopharmacological study on Hypericum species in China. MATERIALS AND METHODS: Classic medicinal books and ethnomedicinal publications were reviewed for the genus Hypericum (called jin si tao in Chinese). In addition, relevant information about ethnobotany, phytochemistry, and pharmacology were from online databases including SciFinder, Science Direct, PubMed, Google Scholar, and China National Knowledge Infrastructure (CNKI). "Hypericum", "", "ethnobotany", "traditional use", "ethnomedicine", "phytochemistry", "pharmacology" and "bioactivity" were used as keywords when searching the databases. Thus, available articles from 1959 to 2019 were collected and analyzed. RESULTS: Among 64 Hypericum species recorded in China, 30 have been used as ethnomedicines by 15 linguistic groups such as Dai, Dong, Han, Miao, and Mongolian people. Hypericum species in China possess traditional uses which are also mirrored in Europe, America, Africa, and other countries in Asia. However, there are some unique ethnomedicinal uses in China. For example, several Hypericum species are used as a local remedy in southwest China, and H. attenuatum Fisch. ex Choisy is used to treat cardiac disorders in northeast China. Antitumor, anti-inflammatory, antimicrobial, neuroprotective, antidepressant, hepatoprotective, cardioprotective, and antiviral activities have been reported in numerous biological studies. The main phytochemical constituents in Hypericum consist of phloroglucinols, naphthodianthrones, xanthones, flavonoids, and terpenoids. CONCLUSIONS: There is a rich traditional knowledge regarding the ethnomedicinal uses of Hypericum species in China. Through phytochemical and pharmacological studies, several medicinal Hypericum from China have yielded many bioactive phytochemicals, possessing antitumor, anti-inflammatory, antimicrobial, and neuroprotective properties. Hypericum species from China are potential sources of drugs to fight cancer and other chronic diseases. Remarkably, nearly half of Hypericum species in China have rarely been studied, and their ethnomedicinal potential have not been scientifically evaluated. Thus, in vitro mechanistic studies, in vivo pharmacology, and clinical efficacy are all needed, prioritizing those studies that relate most closely with their traditional uses. In addition, a comprehensive plant-resource evaluation, quality control, and toxicology studies are needed.
引用
- Zhang R, Ji Y, Zhang X, et al. Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol. 2020. PMID: 32101776. doi:10.1016/j.jep.2020.112686
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。